Stenocare
About Stenocare
Stenocare is Denmark's first and only listed medical cannabis company, trading on Nasdaq First North Growth Market. Based in Aalborg, the company imports and distributes medical cannabis products under Denmark's medical cannabis pilot program. Stenocare has established partnerships with international producers and holds the necessary licenses from the Danish Medicines Agency.
Key Facts
- 1First and only medical cannabis company listed in Denmark
- 2Trades on Nasdaq First North Growth Market under ticker STENO
- 3Operates under Denmark's four-year medical cannabis pilot program
- 4Licensed by the Danish Medicines Agency for cannabis import and distribution
Frequently Asked Questions
What is Denmark's medical cannabis pilot program?
Denmark launched a four-year medical cannabis pilot program in 2018 (extended to 2025) allowing doctors to prescribe cannabis-based medicines. Stenocare is one of the licensed companies participating in this program.
Is Stenocare publicly traded?
Yes, Stenocare trades on Nasdaq First North Growth Market, a Nordic exchange for growth companies. It is the only listed medical cannabis company in Denmark.
More Cannabis Companies in Aalborg
Cannabis Laws
Products
- Medical cannabis oils
- Cannabis flower products
- Standardized cannabis preparations
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Aalborg, Denmark
- Founded
- 2017
- Publicly Traded
- Yes
- Ticker
- Nasdaq First North:STENO